Frequency of Contact Allergy to Implanted Cardiac Devices
نویسندگان
چکیده
منابع مشابه
Interference in implanted cardiac devices, Part I.
Sensing intrinsic cardiac electrical activity is essential for the function of pacemakers and implantable cardioverter defibrillators (ICDs). Examples of undesired triggering or inhibition of pacemaker output by extraneous signals were identified early after the introduction of noncompetitive, “demand” pacemakers. Hermetic shielding in metal cases, filtering, and interference rejection circuits...
متن کاملInterference in implanted cardiac devices, part II.
Patients with implanted cardiac devices (generally of advanced age and with severe cardiovascular disease) often require diagnostic and therapeutic procedures that involve strong sources of EMI. It should be emphasized that with appropriate planning most of these procedures can be performed safely. Consultation regarding exposure to EMI in the medical environment constitutes a frequent clinical...
متن کاملRadiation Therapy to Patients with Cardiac Implanted Electronic Devices
There is an increase of the number of patients with cardiac implantable electronic devices (CIEDs, like pacemakers and cardioverter defibrillators) that require radiotherapy for cancer treatment. Managing such patients has been a great practical and procedural challenge in radiation oncology practice. This editorial will focus on outlining the most important risks of using new techniques of rad...
متن کاملSafety of CMR in patients with cardiac implanted electronic devices
Methods The protocol followed at our institution for MR imaging of CIED patients is as follows: 1) Necessity and absence of an alternative imaging modality; 2) Device-related relative contraindications, including the presence of abandoned leads, pacemaker dependency, and time to lead implant < 6 weeks, with the possibility of the ordering physician to overrule these exclusions. 3) A provider wi...
متن کاملMonitoring patients with implanted cardiac rhythm devices receiving radiation therapy.
629 D iagnosed in 2007 with chronic lymphocytic leukemia (CLL), S.B. was a 78-year-old man. Treatment consisted of a course of rituxumab with stable blood counts. About two years after the initial diagnosis, S.B. presented with a moderately rapidly enlarging mass in his left-anterior shoulder. Biopsy of the mass revealed a Merkel cell carcinoma and, within a month, another mass was noted in his...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA Dermatology
سال: 2019
ISSN: 2168-6068
DOI: 10.1001/jamadermatol.2019.0036